Mandeep Chawla is CFO at CELESTICA INC (CLS). They have made 2 open-market trades across 1 company since 2025, most recently 2026-08-04.
CIK 0001972990
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLS | 65,444 | $19.9M |
Shares reported on the most recent Form 4, priced at the 2026-08-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLS | SELL · 10b5-1 | 2026-08-04 | 2026-08-06 | $369.32 | $6.0M | -1.3% | +4.9% | — |
| CLS | SELL · 10b5-1 | 2026-07-31 | 2026-08-03 | $366.52 | $324K | -0.5% | -20.4% | — |
| CLS | SELL · 10b5-1 | 2026-06-15 | 2026-06-17 | $399.65 | $6.8M | -6.7% | -23.1% | -19.2% |
| CLS | SELL | 2025-02-03 | 2025-02-05 | $122.28 | $22.2M | -2.7% | -35.6% | -30.0% |
| CLS | SELL | 2025-01-31 | 2025-02-03 | $127.54 | $2.4M | +5.8% | -25.9% | -24.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.